Literature DB >> 26199144

Oral Everolimus for Treatment of a Giant Left Ventricular Rhabdomyoma in a Neonate-Rapid Tumor Regression Documented by Real Time 3D Echocardiography.

Robert Wagner1, Frank Thomas Riede1, Hiroshi Seki2, Frauke Hornemann3, Steffen Syrbe3, Ingo Daehnert1, Michael Weidenbach1.   

Abstract

The presented case reports on successful treatment with everolimus in a neonate with left ventricular giant rhabdomyoma. The authors used a different dosage regime compared to literature and documented rapid tumor regression by 3D echocardiography.
© 2015, Wiley Periodicals, Inc.

Entities:  

Keywords:  cardiac tumor; congenital heart diseases; left ventricular outflow obstruction; real time imaging techniques; three-dimensional transthoracic echocardiography

Mesh：

Substances：

Year:  2015        PMID： 26199144     DOI： 10.1111/echo.13015

Source DB:  PubMed          Journal:  Echocardiography        ISSN： 0742-2822            Impact factor:   1.724


  4 in total

1.  Use of Everolimus to treat cardiac rhabdomyomas and incessant arrhythmias in a newborn: Benefits and complications.

Authors:  Eyal Sagiv; Sathish Mallenahalli Chikkabyrappa; Jeffrey Conwell; Mark Lewin; Terrence Un Hoong Chun
Journal:  Ann Pediatr Cardiol       Date:  2022-06-14

2.  Sirolimus-Induced Regression of Tuberous Sclerosis-Associated Cardiac Rhabdomyoma Causing Left Ventricular Outflow Tract Obstruction.

Authors:  Colin Winkie; Jacob Gelman; Pieter Verhoeven; Nita Ray Chaudhuri
Journal:  CASE (Phila)       Date:  2022-05-20

Review 3.  Treatment of Cardiac Rhabdomyomas with mTOR Inhibitors in Children with Tuberous Sclerosis Complex-A Systematic Review.

Authors:  Monika Sugalska; Anna Tomik; Sergiusz Jóźwiak; Bożena Werner
Journal:  Int J Environ Res Public Health       Date:  2021-05-05       Impact factor: 3.390

4.  Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study.

Authors:  Afshin Saffari; Ines Brösse; Adelheid Wiemer-Kruel; Bernd Wilken; Paula Kreuzaler; Andreas Hahn; Matthias K Bernhard; Cornelis M van Tilburg; Georg F Hoffmann; Matthias Gorenflo; Sven Hethey; Olaf Kaiser; Stefan Kölker; Robert Wagner; Olaf Witt; Andreas Merkenschlager; Andreas Möckel; Timo Roser; Jan-Ulrich Schlump; Antje Serfling; Juliane Spiegler; Till Milde; Andreas Ziegler; Steffen Syrbe
Journal:  Orphanet J Rare Dis       Date:  2019-05-03       Impact factor: 4.123
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.